You have 9 free searches left this month | for more free features.

neuroendocrine malignancies

Showing 1 - 25 of 3,569

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Tumors Trial in New York (radiation, device, other)

Recruiting
  • Neuroendocrine Tumors
  • 18F-MFBG (meta-fluoro benzylguanidine)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 31, 2022

Neuroendocrine Tumor Trial in Beijing (18F-MFBG)

Recruiting
  • Neuroendocrine Tumor
  • Beijing, Dongcheng, China
    Peking union medical college hospital
Sep 25, 2021

Pancreatic Cancer Dietary Assessment Study

Completed
  • Pancreatic Neoplasm
  • +3 more
  • Pancreo-KIT breath test
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 1, 2022

Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • PDR001
  • LAG525
  • San Francisco, California
  • +19 more
May 4, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Stanford, California
  • +15 more
Dec 21, 2022

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Urothelial Cancer and Rare Genitourinary Tract Malignancies

    Recruiting
    • Urothelial Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

      Recruiting
      • Advanced Biliary Tract Cancer
      • +3 more
      • Albury, New South Wales, Australia
      • +11 more
      Oct 31, 2022

      Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

      Not yet recruiting
      • Neuroendocrine Carcinomas
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 22, 2023

      Multi-dimensional Fragmentomic Assay for Early Detection of

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Fragmentomic profiles of plasma cfDNA
      • (no location specified)
      Apr 27, 2023

      GastroIntestinal Cancer in Children and Adolescents

      Active, not recruiting
      • Gastrointestinal Cancer
      • +6 more
        • Leiden, South-Holland, Netherlands
        • +1 more
        Jan 11, 2023

        Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

        Not yet recruiting
        • Digestive System Neuroendocrine Tumor G1
        • +5 more
        • Tumor Debulking
        • +5 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Aug 23, 2023

        Neuroendocrine Cancer Trial in United States (Carfilzomib)

        Completed
        • Neuroendocrine Cancer
        • Denver, Colorado
        • +9 more
        Jun 7, 2022

        Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

        Recruiting
        • Neuroendocrine Tumors
        • Innsbruck, Austria
        • +2 more
        May 12, 2023

        Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)

        Recruiting
        • Advanced Pancreatic Cancer
        • Solid Tumor Malignancies
        • Bethesda, Maryland
          National Cancer Institute
        Sep 26, 2022

        Neuroendocrine Tumor, Paraganglioma, Carcinoid Tumors Trial in San Francisco (Computed Tomography (CT), Gallium Ga

        Terminated
        • Neuroendocrine Tumor
        • +3 more
        • Computed Tomography (CT)
        • +3 more
        • San Francisco, California
          University of California, San Francisco
        Oct 21, 2019

        Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

        Recruiting
        • Neuroendocrine Tumor of Pancreas
        • Multiple Endocrine Neoplasia Type 1
        • High-dose-high precision MR-guided radiotherapy
        • Utrecht, Netherlands
          UMC Utrecht
        May 29, 2022

        Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent Trial in United States (RGX-104, Nivolumab, Ipilimumab)

        Recruiting
        • Endometrial Cancer
        • +5 more
        • Los Angeles, California
        • +13 more
        Jul 21, 2022

        Neuroendocrine Tumors, Non-hematologic Malignancy Trial in Japan (Surufatinib)

        Recruiting
        • Neuroendocrine Tumors
        • Non-hematologic Malignancy
        • Fukuoka, Japan
        • +11 more
        Feb 1, 2022

        (PRRT) for the Treatment of Neuroendocrine Tumors

        Enrolling by invitation
        • Neuroendocrine Tumors
        • Peptide Receptor Radionuclide Therapy
        • Dallas, Texas
          Methodist Dallas Medical Center
        Oct 27, 2021

        Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

        Recruiting
        • Neuroendocrine Tumor Grade 2
        • Liver Metastases
        • Capecitabine tablets + temozolomide tablets + SIR-Spheres
        • Philadelphia, Pennsylvania
          Abramson Cancer Center
        Oct 1, 2021

        Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

        Recruiting
        • Pancreatic Cancer
        • +49 more
          • Colorado Springs, Colorado
          • +80 more
          Feb 22, 2022

          Advanced Malignancies Trial in Shanghai (IBI323)

          Recruiting
          • Advanced Malignancies
          • Shanghai, Shanghai, China
            Shang Hai Pulmonary Hospital
          Sep 3, 2021